Bristol Myers Squibb EBIT (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

60.35 +0.05 (+0.08%) USD | NYSE | Feb 20, 11:30

View EBIT (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBIT (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EBIT Definition

Start Trial

EBIT is an acronym for earnings before interest and taxes.

View EBIT (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EBIT (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade
Johnson & Johnson	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Janux Therapeutics, Inc.	Upgrade